<![CDATA[Genmab: Q3 Looking Good, This Antibody Play Is STILL CHEAP]]>"In this no financial advice video, I present Genmab, a leader in antibody medicine and a provider of a novel approach for cancer treatment. I don't understand why Genmab (GMAB stock) is this cheap. No financial advice, but it looks to me like they had a greater Q3.

Let this video be simply a single datapoint in your own analysis of the stock and its potential. As always, this video is NOT investment advice, and none of the contents should be construed as such. I do not make short-term or long-term price predictions for any stock investment, and all words spoken in this video are for entertainment purposes ONLY . Also my Avatar was created with readyplayer.me, a great tool for creating metaverse-ready 3D avatars".

]]>https://dev.proinvestor.com/forum/topic/446817/genmab-q3-looking-good-this-antibody-play-is-still-cheapRSS for NodeWed, 17 Jun 2026 13:32:00 GMTSun, 10 Nov 2024 13:18:38 GMT60